PR Newswire NEW YORK, Jan. 29, 2025 A unique medical memoir from a woman who defied the odds – and her time NEW YORK, Jan. 29, 2025 /PRNewswire/ -- Bestsellers with Brooke-Sidney, a book developer and publisher, announced today the ...
PR Newswire SAN DIEGO, Jan. 29, 2025 First Patient enrolled and treated at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon Advances Hemopurifier® Study in Solid Tumors Not Responding to Anti-PD-1 Antibodies ...
RALEIGH, N.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Returning to work after a cancer diagnosis is a journey fraught with challenges—physical fatigue, emotional hurdles, and workplace reintegration complexities. To bridge this critical gap, ...
PR Newswire LAGUNA BEACH, Calif., Jan. 28, 2025 CRSA Joins Ryght Research Network to Accelerate Access to Novel Cancer Therapies LAGUNA BEACH, Calif., Jan. 28, 2025 /PRNewswire/ -- Ryght AI, a leading provider of real-time generative AI ...
PR Newswire TOKYO, PRINCETON, N.J. and CAMBRIDGE, Mass., Jan. 28, 2025 TOKYO, PRINCETON, N.J. and CAMBRIDGE, Mass., Jan. 28, 2025 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., ...
PR Newswire MOUNTAIN VIEW, Calif. and OSLO, Norway, Jan. 28, 2025 MOUNTAIN VIEW, Calif. and OSLO, Norway, Jan. 28, 2025 /PRNewswire/ -- Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT ...
PR Newswire SINGAPORE, Jan. 24, 2025 Using DNA barcoding, the novel technique tracks and optimises gold nanoparticles for precise drug delivery to tumours, advancing cancer therapies that are safer and more effective SINGAPORE, Jan. 24, ...
PR Newswire ORINDA, Calif., Jan. 23, 2025 ORINDA, Calif., Jan. 23, 2025 /PRNewswire/ -- CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in the San Francisco Bay Area, was established as an independent entity in ...
PR Newswire SAN DIEGO, Jan. 23, 2025 SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting Alluminox™ platform-based photoimmunotherapy, today ...
PR Newswire WEST PALM BEACH, Fla., Jan. 23, 2025 No dose-limiting toxicities, severe adverse events, or on-target off-tumor toxicities across all dose cohorts Deep and durable response observed in gastroesophageal cancer EXUMA now ...
While prostate cancer statistics may seem daunting, advances in detection, treatment, and active surveillance offer patients better outcomes.
Ubiquitin-specific proteases play a critical role in regulating cell death pathways in breast cancer, affecting tumor survival, metastasis, and response to therapy.
New research links metabolism to aggressive breast cancer progression, highlighting the role of insulin resistance and exosomes in worsening outcomes for cancer patients.
Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.
Discover why cancer risk increases with age, exploring genetic changes, weakened immunity, and lifestyle factors affecting elderly and middle-aged individuals.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers